GlassScriptPhysician profile
Christopher R Graber
NPI 1760600415
$4,396.57
in general payments reported to CMS, 2019-2025
18 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $40.67 · 2021: $66.90 · 2022: $3,426 · 2023: $172 · 2024: $215 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,075.74 | 2022 | |
| Fujirebio Diagnostics, Incorporated | $350.00 | 2022 | |
| Abbvie INC. | $198.93 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $173.92 | 2023-2025 | Myfembree |
| Pfizer INC. | $104.93 | 2021-2025 | |
| Biogen, INC. | $84.76 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $71.83 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $67.82 | 2019-2025 | |
| Roche Diagnostics Corporation | $44.01 | 2019 | |
| Becton, Dickinson and Company | $38.02 | 2025 | Bd Onclarity |
| Merck Sharp & Dohme LLC | $37.50 | 2024-2025 | Gardasil 9, Gardasil |
| Organon LLC | $33.61 | 2024 | |
| Coopersurgical, INC. | $31.63 | 2020-2023 | Paragard T 380a |
| Pacira Pharmaceuticals Incorporated | $24.45 | 2025 | Exparel |
| Davol INC. | $20.03 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.74 | 2023 | |
| Myovant Sciences INC. | $12.55 | 2021 | |
| Allergan, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Graber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.